
Sign up to save your podcasts
Or


As COVID-19 spreads globally, populations who survive their illness will become immune. Mayo Vaccine Research Group Director Gregory Poland, MD, discusses antibody responses, duration of immunity, vaccine safety, and the prospects for using convalescent serum to passively immunize people unexposed to SARS-CoV-2.
By JAMA Network4.6
162162 ratings
As COVID-19 spreads globally, populations who survive their illness will become immune. Mayo Vaccine Research Group Director Gregory Poland, MD, discusses antibody responses, duration of immunity, vaccine safety, and the prospects for using convalescent serum to passively immunize people unexposed to SARS-CoV-2.

38,062 Listeners

43,528 Listeners

26,984 Listeners

135 Listeners

319 Listeners

545 Listeners

705 Listeners

506 Listeners

6,435 Listeners

299 Listeners

265 Listeners

3,360 Listeners

22 Listeners

13 Listeners

7 Listeners

7 Listeners

19 Listeners

29 Listeners

93 Listeners

517 Listeners

373 Listeners

17 Listeners

373 Listeners